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Interferon-b is required for interferon-a production in mouse
fibroblasts
Lena Erlandsson*, Ralf Blumenthal†, Maija-Leena Eloranta‡, Holger Engel†,
Gunnar Alm‡, Siegfried Weiss† and Tomas Leanderson*
The type I interferons — interferon-a (IFN-a) and
interferon-b (IFN-b) — are critical for protection against
viruses during the acute stage of viral infection [1,2].
Furthermore, type I interferons have been implicated as
important mediators in the regulation of lymphocyte
development [3], immune responses [4,5] and the
maintenance of immunological memory of cytotoxic T
cells [6,7]. The different IFN-a subtypes are encoded by
12 genes in the mouse [8] whereas IFN-b is encoded for
by only one gene [9]. IFN-a and IFN-b have a high
degree of sequence homology and are thought to
interact with the same surface receptor on target cells
[10,11]. As an approach to analysing the different
biological functions of IFN-a and IFN-b, we have
generated a mouse strain with an inactivated IFN-b
gene. We report here that embryonic fibroblasts from
such mice produce neither IFN-b nor IFN-a upon Sendai
virus infection, whereas the production of IFN-a by
leukocytes from the same strain of mice is intact. IFN-a
production in embryonic fibroblasts from IFN-b–/– mice
could be rescued by ‘priming’ the cells using exogenous
IFN-b. These results imply a unique role for IFN-b in the
induction of type I interferons in peripheral tissues. 
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Results and discussion
In order to inactivate the mouse IFN-β locus, a targeting
construct was generated as depicted in Figure 1a. A mouse
immunoglobulin λ2 chain coding sequence was inserted as
a reporter gene immediately downstream of the IFN-β
promoter, followed by a neomycin cassette. These het-
erologous sequences were grafted onto the IFN-β coding
sequence, eliminating the region encoding the first
4 amino acids, such that no expression was expected from
the modified locus, not even of a truncated IFN-β protein.
The construct was transfected into E14 embryonic stem
cells and a single clone with homologous integration of the
construct in the IFN-β locus was isolated after screening
500 transfectants by Southern blot analysis. Cells of this
clone were injected into C57Bl/6 blastocysts. Offspring of
chimeric mice were used to breed mice heterozygous and
homozygous for a modified IFN-β locus as demonstrated
by the Southern blot in Figure 1b.
In order to study the effect of the introduced mutation in
the IFN-β locus in a situation in which other cytokines,
particularly IFN-γ, do not play a role, we challenged iso-
lated embryonic fibroblasts with Sendai virus in vitro. RNA
was prepared from challenged fibroblasts established from
wild-type littermate controls, IFN-β+/– and IFN-β–/– mice
after 6 hours of culture. As expected, no functional IFN-β
RNA was detected in fibroblasts from the IFN-β–/– mice
using the reverse transcriptase and polymerase chain reac-
tion (RT–PCR) method (Figure 1c,d) or using northern
blot analysis (data not shown). Induction of the λ2 reporter
gene could be observed, however, in fibroblasts from the
IFN-β+/– and IFN-β–/– mice (the low RT–PCR signal from
uninduced fibroblasts from IFN-β+/– and IFN-β–/– mice
was most probably due to contamination with genomic
DNA in the RNA preparations as it was also detected in
control samples from which reverse transcriptase was
omitted; data not shown). We conclude from these results
that we have successfully inactivated the IFN-β locus and
that fibroblasts from such IFN-β–/– mice responded to a
viral challenge by activating the modified IFN-β locus.
We next analysed the IFN-α and IFN-β production
induced by Sendai virus infection of different cell popula-
tions from littermate controls, IFN-β+/– and IFN-β–/– mice
using immunoassays [12]. As shown in Figure 2a, embry-
onic fibroblasts from wild-type littermate control mice pro-
duced both IFN-α and IFN-β, as did IFN-β+/– mice. In
contrast, when fibroblasts from IFN-β–/– mice were chal-
lenged with Sendai virus, no IFN-β production was
detected, as expected. However, no IFN-α production
could be detected in the same cultures. A similar analysis
using spleen (Figure 2b) or bone marrow (Figure 2c) cells
from littermate controls, IFN-β+/– and IFN-β–/– mice
revealed that whereas the IFN-β titer was below the
detection level in IFN-β–/– mice, the IFN-α response was
intact in these cell populations (note that the culture con-
ditions for leukocytes were different from those for fibrob-
lasts; see Materials and methods).
The finding that embryonic fibroblasts from IFN-β–/–
mice were unable to produce IFN-α was puzzling as the
same cells activated the expression of the λ2 reporter gene
after viral challenge (Figure 1d), and thus the signalling
mechanism for the viral infection response was intact. In
addition, the production of IFN-α by spleen and bone
marrow cultures indicated that the IFN-α locus was not
affected by the introduced recombination event. The pos-
sibility remained that, in embryonic fibroblasts, IFN-β
may be needed for the ‘priming’ of IFN-α production
[8,13,14]. To explore this possibility, embryonic fibrob-
lasts from all three types of mice were primed with recom-
binant IFN-β for 2 hours and subsequently challenged
with Sendai virus. As shown in Figure 3, priming with
IFN-β recovered the IFN-α response in embryonic
fibroblasts from IFN-β–/– mice, such that IFN-α was pro-
duced at the same levels as in fibroblasts derived from
wild-type littermate controls or IFN-β+/– mice. Thus,
IFN-β may be pivotal in triggering the production of type
I interferons in non-hematopoetic tissues.
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Inactivation of the mouse IFN-β gene by homologous recombination.
(a) A schematic representation of the mouse IFN-β locus before (top)
and after (bottom) homologous recombination with the targeting vector
displayed in the middle. BamHI (B), EcoRI (E) and PstI (P) restriction
enzyme sites are indicated, as well as the IFN-β gene (black box), the
thymidine kinase gene used for negative selection (TK), λ2 cDNA from
MOPC315 including an SV40-derived splice donator and acceptor
(λ2), a polyadenylation site (light grey box);  the neomycin resistance
gene (neo), and loxP sites not used in the current experiments (dark
grey boxes). The diagnostic HindIII (H) restriction fragments are
indicated on top of the germline configuration and below the targeted
locus, as are the probes used for analysis. (b) Southern blots, using
the indicated probes, of HindIII-digested tail DNA from wild-type
littermate controls (wt), heterozygous (+/–) and homozygous (–/–)
IFN-β-targeted animals. (c,d) Analysis, using the reverse transcriptase
and polymerase chain reaction (RT–PCR) method, of hypoxanthine
phosphoribosyltransferase (HPRT), IFN-β and λ2 RNA from embryonic
fibroblasts of wild-type, IFN-β+/– and IFN-β–/– mice before (c) and after
(d) infection with Sendai virus.
Materials and methods
Mice and homologous recombination
The targeting vector was constructed using conventional molecular
biology techniques. Homology cassettes of the murine IFN-β locus
were subcloned from a cosmid derived from a J129 genomic library
kindly provided by J. Bode (GBF, Braunschweig). For the 5′ homology
region, the 1.2 kb EcoRI–PstI promoter fragment was used. For the 3′
homology region, the 4.5 kb BamHI–PstI fragment that contained most
of the IFN-β structural gene was used. This strategy deleted the 73 bp
PstI–BamHI fragment including the IFN-β translational start codon. The
fragment was replaced by a cDNA corresponding to the λ2 chain of
MOPC315 and a standard neomycin cassette which was flanked by
loxP recombination sites. Electroporation into E14 embryonic stem
cells, G418 selection, isolation of resistant colonies, blastocyst injec-
tions and mouse breeding were carried out according to standard pro-
cedures.
Southern blotting and RT–PCR
Genomic DNA from either embryonic stem cells or tail biopsies was
prepared and analysed by Southern blotting according to standard
procedures. For RT–PCR analysis, semiconfluent embryonic fibrob-
lasts (in 90 mm petri dishes) were cultured in serum-free Iscoves
modified Dulbecco’s medium (IMDM) supplemented with
64 hemagglutination units/ml (HA units/ml) Sendai virus for 5 h, after
which they were washed in phosphate buffered saline (PBS) and
RNA prepared using TrizolTM (Gibco). One half of the recovered RNA
was reverse transcribed in a volume of 20 µl using Superscript
(Gibco) and the cDNA was used as template at various dilutions in
RT–PCR assays. As a negative control, the second half of the RNA
was treated identically, except that the reverse transcriptase was left
out (data not shown). The primers used were IFN-β forward
(sequence deleted in the targeted locus; 5′-TGCATCTTCTCC-
GTCATCTC-3′), IFN-β reverse (5′-TAGCAGCCGACACCAGCCTG-3′),
HPRT forward (5′-GCTGGTGAAAAGGACCTCTCG-3′), HPRT reverse
(5′-GATGGCCACAGGACTAGAACACC-3′), Vλ2 forward (5′-TCT-
GCTCAGGAGCCAGTTCC-3′) and Cλ2 reverse (5′-ACA-
CGGTGAGAGTGGGAGTG-3′). To assure the specificity of the λ2
amplification, the product was transferred to Genescreen plus filters
and hybridised with a Vλ-specific probe (data not shown).
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Figure 2
Quantitation of IFN-α and IFN-β, using
dissociation-enhanced, lanthanide
fluoroimmunoassays, in the supernatants of
Sendai virus infected cell populations from
wild-type, IFN-β+/– and IFN-β—/– mice. The
cells were infected with Sendai virus for 2 h
and the supernatants harvested after an
additional 22 h. (a) Embryonic fibroblasts
(n = 2); (b) splenocytes (n = 3); (c) bone
marrow cells (n = 3).
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(a) Fibroblasts (b) Splenocytes (c) Bone marrow cells
Figure 3
Priming induces IFN-α production in IFN-β—/– fibroblasts. Quantitation
of (a) IFN-β and (b) IFN-α, using dissociation-enhanced, lanthanide
fluoroimmunoassays, in supernatants from Sendai virus infected
embryonic fibroblasts derived from wild-type, IFN-β+/– and IFN-β—/–
mice after priming with 100 U/ml recombinant IFN-β for 2 h before
virus infection (n = 3).
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Tissue culture and virus induction
Embryonic fibroblasts were prepared from day 14 embryos by teasing
the tissue with scissors and two rounds of trypsinisation. The single
cell suspension was plated in tissue culture bottles and non-adherent
cells washed away after 24 h. The fibroblasts were expanded and
either frozen or used for experiments after the first passage. Semi-con-
fluent fibroblasts were induced in serum-free IMDM using
32 HA units/ml Sendai virus for 2 h, after which the cells were washed
with PBS and recultured in IMDM supplemented with 10% fetal calf
serum for 22 h before the supernatants were harvested and analysed
with regard to interferon titer. For priming, the fibroblasts were incu-
bated with 100 U/ml recombinant mouse IFN-β (BioSource Interna-
tional) for 2 h, whereafter the cells were washed and induced with
Sendai virus as described above. Splenocytes and bone marrow cells
were cultured in flat-bottomed 96 well plates in serum-free IMDM with
32 HA units/ml Sendai virus for 22 h, after which the supernatants
were harvested and analysed for interferon content.
Immunoassay of mouse IFN-α and IFN-β
The two dissociation-enhanced, lanthanide fluoroimmunoassays
(DELFIAs) used have been described previously [12]. In brief,
microtitre wells were coated with a sheep anti-mouse IFN-α/β (a kind
gift of M. Tovey, Paris) and developed using rat monoclonal antibodies
to IFN-α (clone 4E-A1) or IFN-β (clone 7F-D3) labelled with Europium
lanthanide chelate (Wallac Oy). Fluorescence, after the addition of
enhancement solution, was measured in a 1234 DELFIA Research
Fluorometer (Wallac). The assays were calibrated against the murine
NIH IFN-α standard Ga02-901-511 and the IFN-β standard Gb02-
902-511.
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